Treprostinil Improves Walk Distance in Pulmonary Hypertension Treprostinil Improves Walk Distance in Pulmonary Hypertension

Exercise capacity increased after patients with pulmonary hypertension associated with interstitial lung disease were treated with the vasodilator for 16 weeks, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news